The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CLOVER HEALTH INVESTMENTS CO | COM CL A | 18914F103 | 784 | 210,639 | SH | SOLE | 210,639 | 0 | 0 | ||
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 558 | 33,125 | SH | SOLE | 33,125 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 415 | 34,887 | SH | SOLE | 34,887 | 0 | 0 | ||
| ISHARES TR | CORE S&P US VLU | 464287663 | 56,506 | 740,195 | SH | SOLE | 740,195 | 0 | 0 | ||
| ISHARES TR | RUS 2000 VAL ETF | 464287630 | 47,071 | 283,472 | SH | SOLE | 283,472 | 0 | 0 | ||
| MONDAY COM LTD | SHS | M7S64H106 | 517 | 1,676 | SH | SOLE | 1,676 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 671 | 34,100 | SH | SOLE | 34,100 | 0 | 0 | ||
| VANGUARD INDEX FDS | VALUE ETF | 922908744 | 60,898 | 413,962 | SH | SOLE | 413,962 | 0 | 0 | ||